Surfactant therapy in preterm infants with respiratory distress syndrome and in near-term or term newborns with acute RDS

被引：0
作者：
R Ramanathan
机构：
[1] Keck School of Medicine of the University of Southern California,
来源：
Journal of Perinatology | 2006年 / 26卷
关键词：
poractant; beractant; preterm infants; nasal continuous positive airway pressure;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Many different surfactant preparations derived from animal sources, as well as synthetic surfactants, are available for the treatment of preterm infants with respiratory distress syndrome (RDS). Natural, modified surfactants containing surfactant-associated proteins appear to be more effective than non-protein-containing synthetic surfactants. Comparative trials with poractant alfa at a higher initial dose of 200 mg/kg appear to be associated with rapid weaning of FiO2, less need for additional doses, and decreased mortality in infants <32 weeks gestation when compared with beractant. Early rescue (<30 min of age) surfactant therapy is an effective method to minimize over treatment of some preterm infants who may not develop RDS. Surfactant therapy followed by rapid extubation to nasal ventilation appears to be more beneficial than continued mechanical ventilation. In near-term or term newborns with acute RDS, surfactant therapy has been shown to be 70% effective in improving respiratory failure.
引用
收藏
页码：S51 / S56
相关论文
共 174 条
  • [21] Rosenberg AA(2005)A randomized trial comparing beractant and poractant treatment in neonatal respiratory distress syndrome Acta Paediatr 94 779-1055
  • [22] Jung AL(2005)Comparison of infasurf (calfactant) and survanta (beractant) in the prevention and treatment of respiratory distress syndrome Pediatrics 116 392-e563
  • [23] Auten RL(2004)A cost minimization comparison of two surfactants, beractant and poractant alfa, based upon prospectively designed, comparative clinical trial data J Pediatr Pharmacol Ther 9 113-46
  • [24] Durand DJ(1994)Surfcatant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome N Engl J Med 331 1051-S328
  • [25] Hudak ML(1999)Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks’ gestation Pediatrics 103 e24-964
  • [26] Martin DJ(2002)Does surfactant and immediate extubation to nasal continuous positive airway pressure reduce use of mechanical ventilation? Pediatr Res 51 349A-52
  • [27] Egan EA(2003)Intratracheal surfactant administration by transient intubation in infants 29–35 weeks’ gestation with RDS requiring nasal CPAP decreases the likelihood of later mechanical ventilation: a randomized controlled trial Pediatr Res 53 367A-47
  • [28] Matteson EJ(2004)Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants <30 weeks’ gestation Pediatrics 113 e560-268
  • [29] Cummings J(2005)Is the new definition of bronchopulmonary dysplasia more useful? J Perinatol 25 41-1087
  • [30] Jung AL(2003)Role of exogenous surfactant in acute lung injury Crit Care Med 31 S324-268
12345678910